Literature DB >> 17560172

Autoimmune disease in families with multiple sclerosis: a population-based study.

Sreeram Varadharajan Ramagopalan1, David Alexandre Dyment, William Valdar, Blanca Marcela Herrera, Maria Criscuoli, Irene Mei Ling Yee, Adele Dessa Sadovnick, George Cornell Ebers.   

Abstract

BACKGROUND: Evidence of an association between multiple sclerosis (MS) and other autoimmune diseases would substantiate the hypothesis that MS is an autoimmune disease, and implicate a common mechanism. We aimed to investigate and compare the rate of autoimmune disease in MS patients, in their first-degree relatives, and in their unrelated spouses.
METHODS: We used data from a national, multicentre, population-based sample to investigate the rate of autoimmune disease in 5031 MS patients, 30 259 of their first-degree relatives, and 2707 spousal controls. We asked patients and controls whether they had any of ten autoimmune diseases: Crohn's disease, ulcerative colitis, rheumatoid arthritis, type 1 diabetes, psoriasis, pernicious anaemia, systemic lupus erythematosus, autoimmune thyroid disease, vitiligo, and myasthenia gravis. MS probands were also asked whether their first-degree relatives had Crohn's disease, ulcerative colitis, rheumatoid arthritis, or type 1 diabetes.
FINDINGS: After correction for age and sex, we did not identify any increased risk of autoimmune diseases in MS patients compared with their spousal controls (odds ratio [OR]=1.07, 95% CI 0.86-1.23, chi(2)=0.47, p=0.49), or in the first-degree relatives of MS probands compared with controls (OR=0.89, 0.63-1.17, chi(2)=1.11, p=0.29). However, the reported frequency of autoimmune diseases did differ according to the sex of the interviewee (female vs male patients chi(2)=92.2, p<0.0001; female vs male spousal controls chi(2)=87.1, p<0.0001). MS patients had slightly higher rates of thyroid disease and pernicious anaemia than did controls, which is consistent with MHC associations for these diseases, but this effect disappeared when results were adjusted for sex. For eight other diseases the rates were similar in MS patients and controls. Families with multiple cases of MS were no more likely to report autoimmune diseases than families with single MS cases.
INTERPRETATION: When data were adjusted for sex, no excess of common autoimmune diseases could be identified in MS patients or their families, including multicase pedigrees. Our results suggest that women are more aware of family medical histories than men, which emphasises the potential for ascertainment bias in unstratified data for a sex-limited disease. Family histories should thus be taken from male patients in the presence of a spouse.

Entities:  

Mesh:

Year:  2007        PMID: 17560172     DOI: 10.1016/S1474-4422(07)70132-1

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN: 1474-4422            Impact factor:   44.182


  49 in total

1.  Smokers with multiple sclerosis are more likely to report comorbid autoimmune diseases.

Authors:  Ruth Ann Marrie; Ralph I Horwitz; Gary Cutter; Tuula Tyry; Timothy Vollmer
Journal:  Neuroepidemiology       Date:  2011-02-01       Impact factor: 3.282

2.  An extremes of outcome strategy provides evidence that multiple sclerosis severity is determined by alleles at the HLA-DRB1 locus.

Authors:  G C DeLuca; S V Ramagopalan; B M Herrera; D A Dyment; M R Lincoln; A Montpetit; M Pugliatti; M C N Barnardo; N J Risch; A D Sadovnick; M Chao; S Sotgiu; T J Hudson; G C Ebers
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-17       Impact factor: 11.205

3.  Multiple sclerosis: autoimmune associations in multiple sclerosis.

Authors:  Cris S Constantinescu; Bruno Gran
Journal:  Nat Rev Neurol       Date:  2010-11       Impact factor: 42.937

4.  Mother-child blood group incompatibility and the risk of multiple sclerosis.

Authors:  Sreeram V Ramagopalan; David A Dyment; Colleen Guimond; Sarah-Michelle Orton; Irene M Yee; George C Ebers; A Dessa Sadovnick
Journal:  J Neurol       Date:  2009-10-01       Impact factor: 4.849

5.  Association of smoking with risk of multiple sclerosis: a population-based study.

Authors:  Sreeram V Ramagopalan; Joshua D Lee; Irene M Yee; Colleen Guimond; Anthony L Traboulsee; George C Ebers; A Dessa Sadovnick
Journal:  J Neurol       Date:  2013-03-02       Impact factor: 4.849

6.  Psoriasis during natalizumab treatment for multiple sclerosis.

Authors:  Jorge Millán-Pascual; Laura Turpín-Fenoll; Pablo Del Saz-Saucedo; Ignacio Rueda-Medina; Santiago Navarro-Muñoz
Journal:  J Neurol       Date:  2012-10-25       Impact factor: 4.849

7.  Analysis of 45 candidate genes for disease modifying activity in multiple sclerosis.

Authors:  Sreeram V Ramagopalan; Gabriele C Deluca; Katie M Morrison; Blanca M Herrera; David A Dyment; Matthew R Lincoln; Sarah-Michelle Orton; Michael J Chao; Alexandra Degenhardt; Maura Pugliatti; A Dessa Sadovnick; Stefano Sotgiu; George C Ebers
Journal:  J Neurol       Date:  2008-06-20       Impact factor: 4.849

Review 8.  Inflammatory bowel disease: an increased risk factor for neurologic complications.

Authors:  Germán Morís
Journal:  World J Gastroenterol       Date:  2014-02-07       Impact factor: 5.742

9.  IL2RA/CD25 gene polymorphisms: uneven association with multiple sclerosis (MS) and type 1 diabetes (T1D).

Authors:  Antonio Alcina; María Fedetz; Dorothy Ndagire; Oscar Fernández; Laura Leyva; Miguel Guerrero; María M Abad-Grau; Carmen Arnal; Concepción Delgado; Miguel Lucas; Guillermo Izquierdo; Fuencisla Matesanz
Journal:  PLoS One       Date:  2009-01-06       Impact factor: 3.240

10.  Age of onset in concordant twins and other relative pairs with multiple sclerosis.

Authors:  A Dessa Sadovnick; Irene M Yee; Colleen Guimond; Jacques Reis; David A Dyment; George C Ebers
Journal:  Am J Epidemiol       Date:  2009-06-22       Impact factor: 4.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.